Practical management and assessment of primary plasma cell leukemia in the novel agent era
Cancer Treat Res Commun
.
2021:28:100414.
doi: 10.1016/j.ctarc.2021.100414.
Epub 2021 Jun 8.
Authors
A Visram
1
,
A Suska
2
,
A Jurczyszyn
2
,
W I Gonsalves
3
Affiliations
1
University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada; Division of Hematology, Mayo Clinic, Rochester, MN, United States.
2
Department of Hematology, Jagiellonian University Medical College, Kopernika 17, Krakow 31-501, Poland.
3
Division of Hematology, Mayo Clinic, Rochester, MN, United States. Electronic address: Gonsalves.wilson@mayo.edu.
PMID:
34174530
PMCID:
PMC8405542
DOI:
10.1016/j.ctarc.2021.100414
No abstract available
Publication types
Review
MeSH terms
Aged
Female
Humans
Leukemia, Plasma Cell / therapy*
Male
Middle Aged
Grants and funding
R01 CA254961/CA/NCI NIH HHS/United States